These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10874465)
1. Treatment of chemotherapy-induced emesis. Egerer G; Hegenbart U; Salwender HJ; Goldschmidt H; Ho AD Antibiot Chemother (1971); 2000; 50():171-83. PubMed ID: 10874465 [No Abstract] [Full Text] [Related]
2. Ondansetron in the control of chemotherapy-induced and radiotherapy-induced emesis in children with malignancies. Zoubek A; Kronberger M; Puschmann A; Gadner H Anticancer Drugs; 1993 Dec; 4 Suppl 2():17-21. PubMed ID: 8136511 [TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis. Bremer K J Cancer Res Clin Oncol; 1991; 117(1):85-7. PubMed ID: 1997476 [No Abstract] [Full Text] [Related]
4. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting. Spitzer TR; Grunberg SM; Dicato MA Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875 [TBL] [Abstract][Full Text] [Related]
6. 5-HT3-receptor antagonists in the control of delayed-onset emesis. Gridelli C Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112 [TBL] [Abstract][Full Text] [Related]
8. Blueprint for the control of radiation-induced nausea and vomiting. Discussion. Horiot JC Acta Oncol; 2004 Sep; 43 Suppl 15():23-4. PubMed ID: 15370627 [No Abstract] [Full Text] [Related]
9. [Chemotherapy-induced emesis and serotonin antagonists]. Jantunen I; Johansson R Duodecim; 1991; 107(14):1112-5. PubMed ID: 1670506 [No Abstract] [Full Text] [Related]
10. Current treatment patterns for radiation-induced nausea and vomiting. Kinay M Acta Oncol; 2004 Sep; 43 Suppl 15():9-12. PubMed ID: 15370624 [No Abstract] [Full Text] [Related]
11. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron. Goldsmith B Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626 [No Abstract] [Full Text] [Related]
13. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone]. Nemec K Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163 [No Abstract] [Full Text] [Related]
14. Granisetron: relating pharmacology to clinical efficacy. Blower PR Support Care Cancer; 2003 Feb; 11(2):93-100. PubMed ID: 12560937 [TBL] [Abstract][Full Text] [Related]
15. Control of emesis associated with cancer chemotherapy. Robinson B N Z Med J; 1993 Feb; 106(950):52-4. PubMed ID: 8437759 [No Abstract] [Full Text] [Related]
16. A pilot study with palonosetron in the prophylaxis of radiation-induced nausea and vomiting. Ganesh V; Drost L; DeAngelis C; Wan BA; Pasetka M; Chan S; Zhang L; Tsao M; Barnes E; Pulenzas N; Chung H; Zaki P; Yee C; Chow E Ann Palliat Med; 2018 Apr; 7(2):211-220. PubMed ID: 29764183 [TBL] [Abstract][Full Text] [Related]
17. Experience with ondansetron in chemotherapy- and radiotherapy-induced emesis. Dicato MA; Freeman AJ Eur J Anaesthesiol Suppl; 1992 Nov; 6():19-24. PubMed ID: 1425621 [TBL] [Abstract][Full Text] [Related]
19. Medicinal plants as antiemetics in the treatment of cancer: a review. Haniadka R; Popouri S; Palatty PL; Arora R; Baliga MS Integr Cancer Ther; 2012 Mar; 11(1):18-28. PubMed ID: 21821652 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials. Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]